Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page
- Check5 days agoChange DetectedThe location label 'Padua, Italy 35128' was updated to 'Padova, Italy 35128' in the locations list.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded B-cell chronic lymphocytic leukemia as a disease term on the page. Included a resources section linking the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedSite revision updated to v3.4.3; the previous revision v3.4.2 has been removed.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded Revision: v3.4.2. Deleted the notice about a lapse in government funding, and the page now reflects the new revision. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check69 days agoChange DetectedA government funding status notice was added and the page revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.